118 related articles for article (PubMed ID: 10343529)
1. Reduced purine 5'-nucleotidase activity in lymphocytes of patients with systemic lupus erythematosus: results of a pilot study.
Stolk JN; de Koning DG; Pennings AH; De Abreu RA; van de Putte LB; Boerbooms AM
Ann Rheum Dis; 1999 Feb; 58(2):122-5. PubMed ID: 10343529
[TBL] [Abstract][Full Text] [Related]
2. Purine metabolism in childhood acute lymphoblastic leukemia: biochemical markers for diagnosis and chemotherapy.
van Laarhoven JP; Spierenburg GT; Bakkeren JA; Schouten TJ; De Bruyn CH; Geerts SJ; Schretlen ED
Leuk Res; 1983; 7(3):407-20. PubMed ID: 6310274
[TBL] [Abstract][Full Text] [Related]
3. Purine enzymes in patients with rheumatoid arthritis treated with methotrexate.
van Ede AE; Laan RF; De Abreu RA; Stegeman AB; van de Putte LB
Ann Rheum Dis; 2002 Dec; 61(12):1060-4. PubMed ID: 12429535
[TBL] [Abstract][Full Text] [Related]
4. Enzymes of purine metabolism in human peripheral lymphocyte subpopulations.
Massaia M; Ma DD; Sylwestrowicz TA; Tidman N; Price G; Janossy G; Hoffbrand AV
Clin Exp Immunol; 1982 Oct; 50(1):148-54. PubMed ID: 6293742
[TBL] [Abstract][Full Text] [Related]
5. Purine enzyme activities in peripheral blood mononuclear cells: comparison of a new non-radiochemical high-performance liquid chromatography procedure and a radiochemical thin-layer chromatography procedure.
Stolk JN; De Abreu RA; Boerbooms AM; de Koning DG; de Graaf R; Kerstens PJ; van de Putte LB
J Chromatogr B Biomed Appl; 1995 Apr; 666(1):33-43. PubMed ID: 7655619
[TBL] [Abstract][Full Text] [Related]
6. Enzymological studies in chronic lymphocytic leukemia.
van Laarhoven JP; de Gast GC; Spierenburg GT; de Bruyn CH
Leuk Res; 1983; 7(2):261-7. PubMed ID: 6406772
[TBL] [Abstract][Full Text] [Related]
7. Comparison of purine degradative enzymes and terminal deoxynucleotidyl transferase in T cell leukaemias and in normal thymic and post-thymic T cells.
Ma DD; Massaia M; Sylwestrowicz TA; Price G; Hoffbrand AV
Br J Haematol; 1983 Jul; 54(3):451-7. PubMed ID: 6305393
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of ecto-5' nucleotidase activity by functionally and phenotypically distinct subpopulations of human Leu-2+/T8+ lymphocytes.
Dianzani U; Massaia M; Pileri A; Grossi CE; Clement LT
J Immunol; 1986 Jul; 137(2):484-9. PubMed ID: 3013991
[TBL] [Abstract][Full Text] [Related]
9. Purine degradative enzymes and immunological phenotypes in chronic B-lymphocytic leukaemia: indications that leukaemic immunocytoma is a separate entity.
Ho AD; Dörken B; Ma DD; Pezzutto A; Hunstein W; Hoffbrand AV
Br J Haematol; 1986 Mar; 62(3):545-55. PubMed ID: 3006740
[TBL] [Abstract][Full Text] [Related]
10. Effect of thymosin and phorbol ester on purine metabolic enzymes and cell surface phenotype in a malignant T-cell line (MOLT-3).
Ho AD; Ma DD; Price G; Hoffbrand AV
Leuk Res; 1983; 7(6):779-86. PubMed ID: 6319830
[TBL] [Abstract][Full Text] [Related]
11. The role of 5'nucleotidase in therapy-resistance of childhood leukemia.
Pieters R; Veerman AJ
Med Hypotheses; 1988 Sep; 27(1):77-80. PubMed ID: 2849709
[TBL] [Abstract][Full Text] [Related]
12. Decreased 5' nucleotidase activity in lymphocytes from asymptomatic sexually active homosexual men and patients with the acquired immune deficiency syndrome.
Murray JL; Reuben JM; Munn CG; Mansell PW; Newell GR; Hersh EM
Blood; 1984 Nov; 64(5):1016-21. PubMed ID: 6091811
[TBL] [Abstract][Full Text] [Related]
13. Decreased ecto-5'nucleotidase activity of peripheral blood lymphocytes in human monoclonal gammopathies: correlation with tumor cell kinetics.
Massaia M; Ma DD; Boccadoro M; Golzio F; Gavarotti P; Dianzani U; Pileri A
Blood; 1985 Mar; 65(3):530-4. PubMed ID: 2982438
[TBL] [Abstract][Full Text] [Related]
14. The generation of alloreactive cytotoxic T lymphocytes requires the expression of ecto-5'nucleotidase activity.
Massaia M; Pileri A; Boccadoro M; Bianchi A; Palumbo A; Dianzani U
J Immunol; 1988 Dec; 141(11):3768-75. PubMed ID: 2846693
[TBL] [Abstract][Full Text] [Related]
15. Purine enzyme activities in recent onset rheumatoid arthritis: are there differences between patients and healthy controls?
Stolk JN; Boerbooms AM; De Abreu RA; Kerstens PJ; de Koning DG; de Graaf R; Mulder J; van de Putte LB
Ann Rheum Dis; 1996 Oct; 55(10):733-8. PubMed ID: 8984938
[TBL] [Abstract][Full Text] [Related]
16. Purine degradative enzymes in circulating malignant cells of patients with chronic B cell neoplasia.
Ho AD; Knauf W; Ganeshaguru K; Hunstein W; Hoffbrand AV
Hematol Oncol; 1987; 5(1):9-17. PubMed ID: 3032762
[TBL] [Abstract][Full Text] [Related]
17. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Bijl M; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
[TBL] [Abstract][Full Text] [Related]
18. In vitro modulation of purine enzyme metabolism and lymphocyte surface marker expression by thymosin fraction 5 in homosexual males.
Murray JL; Reuben JM; Munn CG; Newell G; Mansell PW; Hersh EM
Int J Immunopharmacol; 1985; 7(5):661-9. PubMed ID: 2995264
[TBL] [Abstract][Full Text] [Related]
19. Enzyme analysis of lymphoproliferative diseases: a useful addition to cell surface phenotyping.
van de Griend RJ; van der Reijden HJ; Bolhuis RL; Melief CJ; von dem Borne AE; Roos D
Blood; 1983 Sep; 62(3):669-76. PubMed ID: 6309282
[TBL] [Abstract][Full Text] [Related]
20. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
